DJIA 17,683.58 -46.53 -0.26%
NASDAQ 4,991.94 -17.27 -0.34%
S&P 500 2,068.76 -8.02 -0.39%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

55.43 -0.70 (-1.25%)

REAL-TIME: Last trade at

Extended Hours: $55.94 $0.51 (0.91%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

ISIS $55.43 -1.25%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $55.40
Previous Close $56.13
Daily Range $55.01 - $57.35
52-Week Range $27.37 - $77.80
Market Cap $6.6B
P/E Ratio -280.65
Dividend (Yield) $0.00 (0.0%)
Volume 2,548,121
Average Daily Volume 2,524,873
Current FY EPS -$0.26

Sector

Healthcare

Industry

Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website: http://www.isispharm.com/

News & Commentary

3 Biotech Stocks to Buy As the Greek Tragedy Unfolds

Exelixis, Enanta Pharmaceuticals, and Isis Pharmaceuticals are three names in biotech I'm closely watching in case they fall as a result of the financial crisis in Greece.

Sector's Smaller Players Show The Way

Strong Upward Pre-Market Activity For ISIS Pharmaceuticals (ISIS)

Should Isis Pharmaceuticals (ISIS) Be On Your Radar Now? - Tale of the Tape

Isis Pharmaceuticals Inc. Investors Can Finally Sense a Bright Future

After decades of zero return, Isis Pharmaceuticals' stock has been on fire recently. Is it smart to jump on board now?

Commit To Purchase Isis Pharmaceuticals At $33, Earn 9.1% Using Options

Isis Pharmaceuticals Up on Spinal Muscular Atrophy Data - Analyst Blog

ISIS Pharma Still Undervalued, Needham Says

IWM, CRBN: Big ETF Inflows

Health Care Sector Update for 06/22/2015: PFE, ISIS, KPTI

See More ISIS News...

ISIS's Top Competitors

ISIS $55.43 (-1.25%)
Current stock: ISIS
AMGN $154.50 (0.81%)
Current stock: AMGN
GILD $115.66 (0.54%)
Current stock: GILD
BIIB $404.63 (0.09%)
Current stock: BIIB